23 results
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
27 Feb 24
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company’s Sarcoma Franchise
8:13am
a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal … . The Act further provides that: an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose
424B3
ADAP
Adaptimmune Therapeutics Plc
20 Apr 23
Prospectus supplement
4:32pm
, TCR2 and members of their respective boards of directors challenging the merger, and an adverse ruling in any such lawsuit may delay or prevent … of directors challenging the merger, and an adverse ruling in any such lawsuit may delay or prevent the completion of the merger or result in an award
S-4/A
ADAP
Adaptimmune Therapeutics Plc
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
Adaptimmune, TCR2 and members of their respective boards of directors challenging the merger, and an adverse ruling in any such lawsuit may delay … of directors challenging the merger, and an adverse ruling in any such lawsuit may delay or prevent the completion of the merger or result in an award
S-4
twk2x 3co5u7cz
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
EX-10.01
z5zpe2ir
26 Jan 22
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer
8:05am
8-K
EX-10.1
6bgt410i
16 Dec 20
Departure of Directors or Certain Officers
5:01pm
8-K
EX-10.1
iolthn61 0tioud4h
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
8-K
EX-10.1
wff0czmba
1 Aug 19
New Executive Team Announced at Adaptimmune
7:22am
8-K
EX-10.1
96687wf1o7cc
27 Jun 19
Departure of Directors or Certain Officers
8:08am
10-K
EX-10.20
yoxszccw40qkzt13ygi
13 Mar 17
Annual report
12:00am
10-K
32g8a6jkec6l2fzjb
13 Mar 17
Annual report
12:00am
10-K
EX-10.18
atf oa737
13 Mar 17
Annual report
12:00am